MYRIAD GENETICS INC — Director's Dealing 2014

Apr 25, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2014-04-23

Reporting Person: MARSH RICHARD M (E.V.P., General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-04-23	Common Stock	M	31516.0	$18.06	Acquired	49801	Direct
2014-04-23	Common Stock	S	31516.0	$39.8	Disposed	18285	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-04-23	Non-Qualified Stock Option (right to buy)	$18.06	M	31516.0	Disposed	2017-09-26	Common Stock (31516)	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.